Bringing Emotional Perspective to First-in-Class Treatment
The Challenge
A pre-revenue biopharmaceutical company faced the daunting task of launching a groundbreaking orphan drug designed to treat a rare neurological disorder. Recognizing the intricacies of the pharmaceutical industry and the unique hurdles of marketing within the rare disease space, they sought a partner with deep expertise and a passion for impactful work.
The Solution
Nearly two years prior to the anticipated launch, ClinicalMind was engaged to guide the client through this complex journey. ClinicalMind immersed themselves in the client’s objectives and vision, developing a comprehensive suite of advanced scientific training materials:
Training Modules: Developed 14 in-depth modules, including slides, voice-over content, and pre-/post-testing, covering disease state, testing issues, competitive landscape, and product details.
Online KOL Classroom: Created a virtual classroom to educate field personnel on key disease state insights and the specifics of the new drug.
Preceptorships: Arranged hands-on training programs for deeper learning.
Quarterly Online Forum: Established a regular virtual meeting space for field personnel to discuss and ask questions.
Key educational areas covered in the content included:
Company Information: Enhanced organizational awareness.
Disease-State Education: Provided detailed insights into the neurological disorder.
Product Profile: Highlighted the benefits, safety, and efficacy of the upcoming treatment.
Advocacy Groups: Explained the role and importance of patient advocacy groups.
Competitive Landscape: Provided information on competing technologies in the space.
To add a personal touch, ClinicalMind filmed interviews with clinical trial participants, their families, and physicians. This added a human element to the training, fostering a deeper understanding and connection.
The Results
The training program was highly successful, earning praise from field personnel and client management as the best training they had ever experienced. ClinicalMind’s comprehensive approach ensured that the client’s team was well-prepared and deeply knowledgeable, paving the way for a successful orphan drug launch